<DOC>
	<DOC>NCT01511549</DOC>
	<brief_summary>Primary Objective: To assess the safety and tolerability of SAR113945 in Japanese patients with knee osteoarthritis after ascending single intra-articular doses Secondary Objective: To assess the pharmacokinetics of SAR113945 in Japanese patients with knee osteoarthritis after ascending single intra-articular doses</brief_summary>
	<brief_title>Safety, Tolerability and Pharmacokinetics of SAR113945 in Japanese Patients With Knee Osteoarthritis</brief_title>
	<detailed_description>Following the single dose of study medication, the study period for each patient will be 168 days.</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis, Knee</mesh_term>
	<criteria>Inclusion criteria: Japanese male or female patients, aged 40 years or older, with knee osteoarthritis Diagnosis of primary knee osteoarthritis, based upon the following: Xray or magnetic response imaging (MRI) evidence within the last 6 months for joint space narrowing and osteophyte formation Patients will be Kellegen and Lawrence classification II or III, and total Western Ontario McMaster (WOMAC) score below or equal to 72 Patients fulfilling the American College of Rheumatology Clinical and Radiographic criteria for Osteoarthritis Exclusion criteria: Women of child bearing potential Secondary osteoarthritis: e.g., autoimmune disease, joint dysplasia, aseptic osteonecrosis, acromegaly, Paget's disease, EhlersDanlos syndrome, Gaucher's disease, Stickler's syndrome, joint infection, hemophilia, hemochromatosis, calcium pyrophosphate disposition disease, or neuropathic arthropathy Presence of local skin abnormality at the affected knee joint Any patient who received intraarticular injection within 3 months prior to administration The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>